Glucagon-like peptide 1 agonists and methods of use thereof

WO2026106914A1PCT designated stage Publication Date: 2026-05-21DAHL RUSSELL
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
DAHL RUSSELL
Filing Date
2025-11-10
Publication Date
2026-05-21

Smart Images

  • Figure US2025054805_21052026_PF_FP_ABST
    Figure US2025054805_21052026_PF_FP_ABST
Patent Text Reader

Abstract

Disclosed herein are compounds of Formula (I). Pharmaceutically acceptable salts of the same, pharmaceutical composition comprising the same, and methods of treating diseases using the same are also disclosed.
Need to check novelty before this filing date? Find Prior Art